Verseon Corporation Update on Facility Sale-Leaseback (0120R)
24 Octubre 2019 - 3:43AM
UK Regulatory
TIDMVERS
RNS Number : 0120R
Verseon Corporation
24 October 2019
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF THE MARKET ABUSE REGULATION (596/2014/EU) ("MAR"). WITH THE
PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION
SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE
PUBLIC DOMAIN.
October 24, 2019
Verseon Corporation
("Verseon" or the "Company")
Update on Sale-Leaseback of Verseon's Research, Development, and
Operations Facility
FREMONT, Calif.-Further to the announcement of October 23, 2019,
Verseon Corporation (AIM: VERS), a clinical-stage pharmaceutical
company, today announces that it will not be in a position to sign
the sale-leaseback for its research, development, and operations
facility in Fremont, CA, (the "Facility") disclosed in yesterday's
announcement ahead of the Annual General Meeting of Shareholders
convened for October 28, 2019 ("AGM").
In order to enable the directors of the Company to enter into a
sale-leaseback of the Facility and to consider options available to
the Company, the resolution relating to the sale-leaseback will
remain on the agenda for the AGM. The vote will proceed on the
basis that the terms of the final sale-leaseback agreement will be
materially similar or better than those announced on October 23,
2019.
- Ends -
For further information, please contact
Verseon Corporation www.verseon.com
Sebastian Wykeham / Tina Schlafly +1 (510) 225 9000
Arden Partners (NOMAD and Broker)
Ruari McGirr / Ciaran Walsh / Dan Gee-Summons
(Corporate Finance) / Fraser Marshall +44 (0) 20 7614
(Equity Sales) 5900
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737 821
Simon Vane Percy 890
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
UPDCKQDQFBDKDKB
(END) Dow Jones Newswires
October 24, 2019 04:43 ET (08:43 GMT)
Verseon (LSE:VERS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Verseon (LSE:VERS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024